145 related articles for article (PubMed ID: 26731274)
1. Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoE-Deficient Mice.
Jehle J; Hoyer FF; Schöne B; Pfeifer P; Schild K; Jenniches I; Bindila L; Lutz B; Lütjohann D; Zimmer A; Nickenig G
PLoS One; 2016; 11(1):e0146267. PubMed ID: 26731274
[TBL] [Abstract][Full Text] [Related]
2. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.
Hoyer FF; Steinmetz M; Zimmer S; Becker A; Lütjohann D; Buchalla R; Zimmer A; Nickenig G
J Mol Cell Cardiol; 2011 Dec; 51(6):1007-14. PubMed ID: 21884703
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE-/- mice.
Jehle J; Schöne B; Bagheri S; Avraamidou E; Danisch M; Frank I; Pfeifer P; Bindila L; Lutz B; Lütjohann D; Zimmer A; Nickenig G
PLoS One; 2018; 13(5):e0197751. PubMed ID: 29813086
[TBL] [Abstract][Full Text] [Related]
4. Perilipin1 deficiency in whole body or bone marrow-derived cells attenuates lesions in atherosclerosis-prone mice.
Zhao X; Gao M; He J; Zou L; Lyu Y; Zhang L; Geng B; Liu G; Xu G
PLoS One; 2015; 10(4):e0123738. PubMed ID: 25855981
[TBL] [Abstract][Full Text] [Related]
5. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
[TBL] [Abstract][Full Text] [Related]
7. Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.
Stöger JL; Boshuizen MC; Brufau G; Gijbels MJ; Wolfs IM; van der Velden S; Pöttgens CC; Vergouwe MN; Wijnands E; Beckers L; Goossens P; Kerksiek A; Havinga R; Müller W; Lütjohann D; Groen AK; de Winther MP
Thromb Haemost; 2016 Aug; 116(3):565-77. PubMed ID: 27358035
[TBL] [Abstract][Full Text] [Related]
8. 2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.
Schloss MJ; Horckmans M; Guillamat-Prats R; Hering D; Lauer E; Lenglet S; Weber C; Thomas A; Steffens S
Cardiovasc Res; 2019 Mar; 115(3):602-613. PubMed ID: 30295758
[TBL] [Abstract][Full Text] [Related]
9. Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.
Xie P; Zeng X; Xiao J; Sun B; Yang D
Biochim Biophys Acta; 2014 Dec; 1841(12):1683-90. PubMed ID: 25178844
[TBL] [Abstract][Full Text] [Related]
10. Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe
Leipner J; Dederichs TS; von Ehr A; Rauterberg S; Ehlert C; Merz J; Dufner B; Hoppe N; Krebs K; Heidt T; von Zur Muehlen C; Stachon P; Ley K; Wolf D; Zirlik A; Bode C; Hilgendorf I; Härdtner C
Mol Metab; 2021 Nov; 53():101250. PubMed ID: 33991749
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
Hoyer FF; Khoury M; Slomka H; Kebschull M; Lerner R; Lutz B; Schott H; Lütjohann D; Wojtalla A; Becker A; Zimmer A; Nickenig G
J Mol Cell Cardiol; 2014 Jan; 66():126-32. PubMed ID: 24286707
[TBL] [Abstract][Full Text] [Related]
12. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
14. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
18. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
19. B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation.
Tay C; Liu YH; Hosseini H; Kanellakis P; Cao A; Peter K; Tipping P; Bobik A; Toh BH; Kyaw T
Cardiovasc Res; 2016 Sep; 111(4):385-97. PubMed ID: 27492217
[TBL] [Abstract][Full Text] [Related]
20. Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis.
Montecucco F; Matias I; Lenglet S; Petrosino S; Burger F; Pelli G; Braunersreuther V; Mach F; Steffens S; Di Marzo V
Atherosclerosis; 2009 Aug; 205(2):433-41. PubMed ID: 19187936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
